Does OBINUTUZUMAB Cause Intentional product use issue? 205 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 205 reports of Intentional product use issue have been filed in association with OBINUTUZUMAB (Gazyva). This represents 1.4% of all adverse event reports for OBINUTUZUMAB.
205
Reports of Intentional product use issue with OBINUTUZUMAB
1.4%
of all OBINUTUZUMAB reports
21
Deaths
26
Hospitalizations
How Dangerous Is Intentional product use issue From OBINUTUZUMAB?
Of the 205 reports, 21 (10.2%) resulted in death, 26 (12.7%) required hospitalization, and 3 (1.5%) were considered life-threatening.
Is Intentional product use issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OBINUTUZUMAB. However, 205 reports have been filed with the FAERS database.
What Other Side Effects Does OBINUTUZUMAB Cause?
Off label use (1,584)
Neutropenia (1,276)
Febrile neutropenia (955)
Covid-19 (942)
Pyrexia (920)
Thrombocytopenia (889)
Disease progression (831)
Infusion related reaction (789)
Pneumonia (662)
Anaemia (640)
What Other Drugs Cause Intentional product use issue?
INFLIXIMAB (11,028)
RITUXIMAB (9,602)
INFLIXIMAB-DYYB (7,549)
TOCILIZUMAB (5,078)
METHOTREXATE (4,087)
PREDNISONE (3,961)
ABATACEPT (3,693)
ADALIMUMAB (3,557)
NIVOLUMAB (3,297)
LEFLUNOMIDE (3,280)
Which OBINUTUZUMAB Alternatives Have Lower Intentional product use issue Risk?
OBINUTUZUMAB vs OCELLA
OBINUTUZUMAB vs OCRELIZUMAB
OBINUTUZUMAB vs OCRIPLASMIN
OBINUTUZUMAB vs OCTINOXATE\OCTISALATE\ZINC
OBINUTUZUMAB vs OCTINOXATE\OCTOCRYLENE